RECOGNITION AND ASSESSMENT
Definition
- Peripheral venous haematocrit (Hct) >65%
- Symptoms rarely occur with peripheral Hct of <70%
- Hct peaks at 2 hr after birth and then decreases with significant changes occurring by 6 hr
Clinical consequences
- Hyperviscosity
- Decreased blood flow and impaired tissue perfusion
- Thrombus formation
Complications
- Cerebral micro-infarction and adverse neurodevelopmental outcome
- Renal vein thrombosis
- Necrotising enterocolitis (NEC)
Causes
Intra-uterine increased erythropoiesis | Erythrocyte transfusion |
|
|
Symptoms and signs
- Commonly plethoric but asymptomatic
Cardiorespiratory |
|
CNS |
|
GIT |
|
Metabolic |
|
Haematological |
|
Renal |
|
INVESTIGATIONS
In all unwell babies and at-risk babies who look plethoric (as mentioned above)
- FBC/Hct
- If Hct >65%, repeat a free-flowing venous sample or obtain arterial Hct (capillary Hct sample unreliable)
- If polycythaemic, check blood glucose and serum calcium
IMMEDIATE TREATMENT
- Ensure babies at risk have liberal fluid intake 1 day ahead of usual requirement (see Intravenous fluid therapy guideline)
Asymptomatic babies with Hct >70%
- Repeat venous Hct after 6 hr
- if still high, discuss with consultant
Symptomatic babies with Hct >65%
- Possible symptoms: fits and excessive jitteriness, with neurological signs and refractory hypoglycaemia
Treatment
- Dilutional/partial exchange transfusion. Discuss with consultant
- use of haemodilution for treatment of polycythaemia is not supported by evidence and treatment of asymptomatic babies is not recommended
- explain to parents the need for exchange and possible risks before performing partial exchange transfusion. Partial exchange transfusion increases risk of NEC
- use sodium chloride 0.9% (see Exchange transfusion guideline)
- Volume to be exchanged = 20 mL/kg
- Perform exchange via peripheral arterial and IV lines or via umbilical venous catheter
- Take 5–10 mL aliquots and complete procedure over 15–20 min
SUBSEQUENT MANAGEMENT
- Babies who required partial exchange transfusion require long-term neurodevelopmental follow-up
- Otherwise, follow-up will be dependent on background problem
Date updated: 2024-02-05